Haloperidol for the treatment of delirium in critically ill patients: A systematic review with meta-analysis and Trial Sequential Analysis.

Marija BarbateskovicSara R KraussMarie Oxenbøll Collet Nina Christine Andersen-Ranberg Ole Mathiesen Janus Christian Jakobsen Anders Perner Jorn Wetterslev

Published in: Acta anaesthesiologica Scandinavica (2019)

The evidence for the use of haloperidol to treat critically ill patients with delirium is sparse, of low quality and inconclusive. We therefore have no certainty regarding any beneficial, harmful or neutral effects of haloperidol in these patients.

Keyphrases

end stage renal disease
cardiac surgery
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
peritoneal dialysis
hip fracture
patient reported outcomes
phase iii
open label
replacement therapy